Eikon Therapeutics Inc (EIKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -324,248 | -243,814 |
| Depreciation Amortization | 24,176 | 25,392 |
| Accounts payable and accrued liabilities | -3,813 | 2,951 |
| Other Working Capital | 77,835 | 80,650 |
| Other Operating Activity | 37,534 | 22 |
| Operating Cash Flow | $-188,516 | $-134,799 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -46,741 | -84,803 |
| Purchase Of Investment | -444,102 | -360,347 |
| Sale Of Investment | 309,500 | 596,500 |
| Investing Cash Flow | $-181,343 | $151,350 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,900 | 244 |
| Other Financing Activity | 350,153 | 0 |
| Financing Cash Flow | $352,053 | $244 |
| Beginning Cash Position | 130,878 | 114,083 |
| End Cash Position | 113,072 | 130,878 |
| Net Cash Flow | $-17,806 | $16,795 |
| Free Cash Flow | ||
| Operating Cash Flow | -188,516 | -134,799 |
| Capital Expenditure | -46,741 | -84,803 |
| Free Cash Flow | -235,257 | -219,602 |